Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Citi
AstraZeneca
Harvard Business School
Farmers Insurance
Johnson and Johnson
Baxter
Cantor Fitzgerald
Express Scripts
Cerilliant

Generated: January 18, 2018

DrugPatentWatch Database Preview

Details for Patent: 4,772,475

« Back to Dashboard

Summary for Patent: 4,772,475
Title: Controlled-release multiple units pharmaceutical formulation
Abstract:A pharmaceutical controlled-release individual unit or multiple units formulation in which the individual unit comprises a granulation product obtained by adding a release controlling agent to a mixture of a physiologically active substance and units-forming substance(s) and granulating and resultant mixture, said granulation product (granules) being substantially not disintegrated but gradually releasing the physiologically active substance in the gastrointestinal tract.
Inventor(s): Fukui; Muneo (Saitama, JP), Tomuro; Kouji (Saitama, JP), Masuyama; Shigeru (Saitama, JP), Kajiyama; Atsushi (Saitama, JP), Hikosaka; Tamio (Saitama, JP), Aruga; Masayoshi (Saitama, JP), Higuchi; Saburo (Saitama, JP), Soeishi; Yoshiaki (Tokyo, JP)
Assignee: Yamanouchi Pharmaceutical Co., Ltd. (Tokyo, JP)
Application Number:06/833,961
Patent Claim Types:
see list of patent claims
Formulation; Compound;

Drugs Protected by US Patent 4,772,475

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Foreign Priority and PCT Information for Patent: 4,772,475

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Japan60-46180Mar 08, 1985

International Patents Family Members for US Patent 4,772,475

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Canada 1264293 ➤ Subscribe
Germany 3650657 ➤ Subscribe
Germany 3688532 ➤ Subscribe
European Patent Office 0194838 ➤ Subscribe
European Patent Office 0533297 ➤ Subscribe
Spain 552794 ➤ Subscribe
Spain 8800041 ➤ Subscribe
Japan H0772129 ➤ Subscribe
Japan S629 ➤ Subscribe
South Korea 930007245 ➤ Subscribe
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Cipla
McKesson
AstraZeneca
Cantor Fitzgerald
Colorcon
Medtronic
Deloitte
Federal Trade Commission
UBS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot